Lack of effect of statins on maintenance of normal sinus rhythm following electrical cardioversion of persistent atrial fibrillation

International Journal of Clinical Practice

Volumn 64, Issue 8, 2010, Pages 1116-1120

  Bhardwaj, A ^a,b   Sood, N A ^a,b   Kluger, J ^a,b   Coleman, C I ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b HARTFORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; PRAVASTATIN;

ARTICLE; CARDIOVERSION; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; DISEASE DURATION; DRUG EFFECT; HEART ATRIUM FIBRILLATION; HUMAN; MEDICAL LITERATURE; META ANALYSIS; PRIORITY JOURNAL; PUBLICATION; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; SYSTEMATIC REVIEW;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; TREATMENT FAILURE;

EID: 77953849455     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02387.x     Document Type: Article

References (27)

1. Fuster V, Ryden L, Cannom D et al. ACC/AHA/ESC 2006 guidelines for the management of patients with AF. J Am Coll Cardiol 2006 48 : 854 906.
2. The AFFIRM Investigators. Survival in patients presenting with atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. N Engl J Med 2002 347 : 1825 1833.
3. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976 235 : 39 41.
4. Aviles RJ, Martin DO, Apperson-Hansen C et al. Inflammation as a risk factor for AF. Circulation 2003 108 : 3006 3010.
5. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of AF: a systematic review of the published data. J Am Coll Cardiol 2007 50 : 2021 2028.
6. Naji F, Suran D, Kanic V, Vokac D, Sabovic M. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion. Med Sci Monit 2009 15 : CR494 8.
7. Humphries KH, Lee M, Sheldon R et al. Statin use and recurrence of atrial fibrillation after successful cardioversion. Am Heart J 2007 154 : 908 913.
8. Siu CW, Lau CP, Tse HF. Prevention of atrial fibrillation recurrence by statin therapy in patients with lone atrial fibrillation after successful cardioversion. Am J Cardiol 2003 92 : 1343 1345.
9. Almroth H, Höglund N, Boman K et al. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. Eur Heart J 2009 30 : 827 833.
10. Ozaydin M, Varol E, Aslan SM et al. Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006 97 : 1490 1493.
11. García-Fernández A, Marín F, Mainar L, Roldán V, Martínez JG. Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2006 98 : 1299 1300.
12. Liu T, Li L, Korantzopoulos P, Liu E, Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 2008 126 : 160 170.
13. Tveit A, Grundtvig M, Gundersen T et al. Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion. Am J Cardiol 2004 93 : 780 782.
14. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997 96 : 1180 1184.
15. Morgera T, Di Lenarda A, Dreas L et al. Electrocardiography of myocarditis revisited: clinical and prognostic significance of electrocardiographic changes. Am Heart J 1992 124 : 455 467.
16. Bruins P, te Velthuis H, Yazdanbakhsh AP et al. Activation of the complement system during and after cardiopulmonary bypass surgery: postsurgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997 96 : 3542 3548.
17. Malouf JF, Kanagala R, Al Atawi FO et al. High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. J Am Coll Cardiol 2005 46 : 1284 1287.
18. Young-Xu Y, Jabbour S, Goldberg R et al. Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease. Am J Cardiol 2003 92 : 1379 1383.
19. Dickinson M, Hellkamps A, Ip JH et al. Statin therapy was associated with reduced atrial fibrillation and flutter in heart failure patients in SCD-HeFT. Heart Rhythm 2006 3 (Suppl. 1 S49.
20. Hanna I, Heeke B, Bush H et al. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm 2006 3 : 881 886.
21. Adabag S, Nelson D, Bloomfield H. Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure. Am Heart J 2007 154 : 1140 1145.
22. Merckx K, Tieleman R, Folkeringa R et al. Use of statins is associated with reduced incidence of atrial fibrillation in patients with left ventricular hypertrophy and left atrial dilatation. Heart Rhythm 2004 1 (Suppl. 1 S105.
23. Dernellis J, Panaretou M. Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. Am Heart J 2005 150 : 1064.
24. Patti G, Chello M, Candura D et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006 114 : 1455 1461.
25. Richter B, Derntl M, Marx M, Lercher P, Gossinger D. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation. Am Heart J 2007 153 : 113 119.
26. Amit G, Katz A, Bar-On S et al. Association of statin therapy and the risk of atrial fibrillation in patients with a permanent pacemaker. Clin Cardiol 2006 29 : 249 252.
27. Naji F, Suran D, Kanic V, Vokac D, Sabovic M. Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion. Int Heart J 2009 50 : 153 160.